CN104784415A - 一种用治疗急性出疹性传染疾病的中药丸剂及制备方法 - Google Patents
一种用治疗急性出疹性传染疾病的中药丸剂及制备方法 Download PDFInfo
- Publication number
- CN104784415A CN104784415A CN201510133996.8A CN201510133996A CN104784415A CN 104784415 A CN104784415 A CN 104784415A CN 201510133996 A CN201510133996 A CN 201510133996A CN 104784415 A CN104784415 A CN 104784415A
- Authority
- CN
- China
- Prior art keywords
- radix
- immersion
- pill
- medicine
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 53
- 239000006187 pill Substances 0.000 title claims abstract description 19
- 230000001154 acute effect Effects 0.000 title claims abstract description 13
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 208000015181 infectious disease Diseases 0.000 title abstract description 4
- 208000035473 Communicable disease Diseases 0.000 title abstract 2
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 claims abstract description 13
- 235000010894 Artemisia argyi Nutrition 0.000 claims abstract description 12
- 241001435059 Artemisia argyi Species 0.000 claims abstract description 12
- 238000007654 immersion Methods 0.000 claims description 24
- 239000009636 Huang Qi Substances 0.000 claims description 15
- 239000000843 powder Substances 0.000 claims description 15
- 235000003351 Brassica cretica Nutrition 0.000 claims description 12
- 235000003343 Brassica rupestris Nutrition 0.000 claims description 12
- 241000756943 Codonopsis Species 0.000 claims description 12
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- 235000010460 mustard Nutrition 0.000 claims description 12
- 235000000177 Indigofera tinctoria Nutrition 0.000 claims description 11
- 229940097275 indigo Drugs 0.000 claims description 11
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 claims description 11
- 239000004615 ingredient Substances 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 239000002994 raw material Substances 0.000 claims description 9
- 238000001816 cooling Methods 0.000 claims description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 6
- 238000010410 dusting Methods 0.000 claims description 6
- 238000001704 evaporation Methods 0.000 claims description 6
- 230000008020 evaporation Effects 0.000 claims description 6
- 238000010298 pulverizing process Methods 0.000 claims description 6
- 235000019991 rice wine Nutrition 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 235000015099 wheat brans Nutrition 0.000 claims description 6
- 238000012545 processing Methods 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 4
- 235000019504 cigarettes Nutrition 0.000 claims description 3
- 210000002615 epidermis Anatomy 0.000 claims description 3
- 235000012907 honey Nutrition 0.000 claims description 3
- 229910052742 iron Inorganic materials 0.000 claims description 3
- 230000007480 spreading Effects 0.000 claims description 3
- 238000003892 spreading Methods 0.000 claims description 3
- 244000056139 Brassica cretica Species 0.000 claims 1
- 210000004369 blood Anatomy 0.000 abstract description 31
- 239000008280 blood Substances 0.000 abstract description 31
- 230000000694 effects Effects 0.000 abstract description 27
- 201000005404 rubella Diseases 0.000 abstract description 24
- 208000003251 Pruritus Diseases 0.000 abstract description 23
- 230000001737 promoting effect Effects 0.000 abstract description 18
- 230000017531 blood circulation Effects 0.000 abstract description 14
- 230000007803 itching Effects 0.000 abstract description 11
- 230000001717 pathogenic effect Effects 0.000 abstract description 7
- 230000001105 regulatory effect Effects 0.000 abstract description 6
- 230000002411 adverse Effects 0.000 abstract description 5
- 239000000463 material Substances 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 238000012795 verification Methods 0.000 abstract description 4
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 235000005637 Brassica campestris Nutrition 0.000 abstract 1
- 241001301148 Brassica rapa subsp. oleifera Species 0.000 abstract 1
- 241000931705 Cicada Species 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 244000075634 Cyperus rotundus Species 0.000 abstract 1
- 235000016854 Cyperus rotundus Nutrition 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 241000119904 Elsholtzia blanda Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 241000096284 Gynochthodes officinalis Species 0.000 abstract 1
- 241000209035 Ilex Species 0.000 abstract 1
- 235000003332 Ilex aquifolium Nutrition 0.000 abstract 1
- 235000002296 Ilex sandwicensis Nutrition 0.000 abstract 1
- 235000002294 Ilex volkensiana Nutrition 0.000 abstract 1
- 241001571736 Lysimachia foenum-graecum Species 0.000 abstract 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 abstract 1
- 235000011613 Pinus brutia Nutrition 0.000 abstract 1
- 241000018646 Pinus brutia Species 0.000 abstract 1
- 241000405911 Rehmannia glutinosa Species 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 241000124033 Salix Species 0.000 abstract 1
- 241000951473 Schizonepeta Species 0.000 abstract 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract 1
- 244000126002 Ziziphus vulgaris Species 0.000 abstract 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 230000000295 complement effect Effects 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 description 24
- 210000000952 spleen Anatomy 0.000 description 21
- 231100000614 poison Toxicity 0.000 description 18
- 210000004185 liver Anatomy 0.000 description 16
- 239000003440 toxic substance Substances 0.000 description 16
- 206010011224 Cough Diseases 0.000 description 14
- 208000002193 Pain Diseases 0.000 description 14
- 235000009508 confectionery Nutrition 0.000 description 14
- 230000008961 swelling Effects 0.000 description 14
- 208000006820 Arthralgia Diseases 0.000 description 12
- 241000411851 herbal medicine Species 0.000 description 12
- 241000219198 Brassica Species 0.000 description 11
- 210000003734 kidney Anatomy 0.000 description 11
- 210000002784 stomach Anatomy 0.000 description 10
- 206010007247 Carbuncle Diseases 0.000 description 9
- 230000007812 deficiency Effects 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 206010062717 Increased upper airway secretion Diseases 0.000 description 8
- 208000014674 injury Diseases 0.000 description 8
- 208000026435 phlegm Diseases 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 210000003491 skin Anatomy 0.000 description 7
- 208000010201 Exanthema Diseases 0.000 description 6
- 238000012790 confirmation Methods 0.000 description 6
- 201000005884 exanthem Diseases 0.000 description 6
- 206010037844 rash Diseases 0.000 description 6
- 206010063409 Acarodermatitis Diseases 0.000 description 5
- 241000447727 Scabies Species 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 208000005687 scabies Diseases 0.000 description 5
- 239000003053 toxin Substances 0.000 description 5
- 231100000765 toxin Toxicity 0.000 description 5
- 230000008736 traumatic injury Effects 0.000 description 5
- 235000014101 wine Nutrition 0.000 description 5
- 201000004624 Dermatitis Diseases 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 201000000297 Erysipelas Diseases 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- 206010025421 Macule Diseases 0.000 description 4
- 206010033557 Palpitations Diseases 0.000 description 4
- 208000025747 Rheumatic disease Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 230000001139 anti-pruritic effect Effects 0.000 description 4
- 239000003908 antipruritic agent Substances 0.000 description 4
- 206010003549 asthenia Diseases 0.000 description 4
- 208000006673 asthma Diseases 0.000 description 4
- 208000010668 atopic eczema Diseases 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000000552 rheumatic effect Effects 0.000 description 4
- 206010010904 Convulsion Diseases 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 241000710799 Rubella virus Species 0.000 description 3
- 206010043376 Tetanus Diseases 0.000 description 3
- 230000000954 anitussive effect Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 229940124584 antitussives Drugs 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000006735 deficit Effects 0.000 description 3
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 210000003026 hypopharynx Anatomy 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 210000003800 pharynx Anatomy 0.000 description 3
- 208000037920 primary disease Diseases 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 208000005584 Alcoholic Intoxication Diseases 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 208000033386 Buerger disease Diseases 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 2
- 206010019468 Hemiplegia Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 206010033425 Pain in extremity Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 206010043540 Thromboangiitis obliterans Diseases 0.000 description 2
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 229940035676 analgesics Drugs 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 239000000730 antalgic agent Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 230000000767 anti-ulcer Effects 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 229910021538 borax Inorganic materials 0.000 description 2
- 239000008338 calamine lotion Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 201000005917 gastric ulcer Diseases 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 238000009738 saturating Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 239000004328 sodium tetraborate Substances 0.000 description 2
- 235000010339 sodium tetraborate Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 description 2
- NQWVSMVXKMHKTF-JKSUJKDBSA-N (-)-Arctigenin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O)=CC=2)C(=O)OC1 NQWVSMVXKMHKTF-JKSUJKDBSA-N 0.000 description 1
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010002953 Aphonia Diseases 0.000 description 1
- YYGRXNOXOVZIKE-UHFFFAOYSA-N Arctigenin Natural products COC1CCC(CC2COC(=O)C2CC3CCC(O)C(C3)OC)CC1OC YYGRXNOXOVZIKE-UHFFFAOYSA-N 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010004053 Bacterial toxaemia Diseases 0.000 description 1
- HKTRVQKOJIKDSB-AGWHVNJWSA-N CC1(C)[C@H](O)[C@H](O)C[C@]2(C)[C@H]3CC[C@H]4[C@@](C)(CC[C@H]5[C@@](C)(CO)[C@H](O)CC[C@]45C)C=C3CC(=O)[C@@H]12 Chemical compound CC1(C)[C@H](O)[C@H](O)C[C@]2(C)[C@H]3CC[C@H]4[C@@](C)(CC[C@H]5[C@@](C)(CO)[C@H](O)CC[C@]45C)C=C3CC(=O)[C@@H]12 HKTRVQKOJIKDSB-AGWHVNJWSA-N 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
- 208000003569 Central serous chorioretinopathy Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 208000003606 Congenital Rubella Syndrome Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 206010011469 Crying Diseases 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
- 206010059284 Epidermal necrosis Diseases 0.000 description 1
- 241001480035 Epidermophyton Species 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 206010052140 Eye pruritus Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010018286 Gingival pain Diseases 0.000 description 1
- 206010018291 Gingival swelling Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- OIFFJDGSLVHPCW-UHFFFAOYSA-N Guayarol Natural products COc1ccc(CC2C(Cc3ccc(O)c(O)c3)COC2=O)cc1OC OIFFJDGSLVHPCW-UHFFFAOYSA-N 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- 206010021531 Impetigo Diseases 0.000 description 1
- NQWVSMVXKMHKTF-UHFFFAOYSA-N L-Arctigenin Natural products C1=C(OC)C(OC)=CC=C1CC1C(CC=2C=C(OC)C(O)=CC=2)C(=O)OC1 NQWVSMVXKMHKTF-UHFFFAOYSA-N 0.000 description 1
- 201000008197 Laryngitis Diseases 0.000 description 1
- MJRWKTJXJHISTD-UHFFFAOYSA-N Lycoclavanin Natural products CC1C(O)C(O)CC2(C)C3CCC4C(CCC5C(CO)C(O)CCC45C)CC3=CC(=O)C12 MJRWKTJXJHISTD-UHFFFAOYSA-N 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 206010051986 Pneumatosis Diseases 0.000 description 1
- 208000037048 Prodromal Symptoms Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 208000019802 Sexually transmitted disease Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 241000193990 Streptococcus sp. 'group B' Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 201000002014 Suppurative Otitis Media Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 208000013222 Toxemia Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 206010044684 Trismus Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010058874 Viraemia Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- MDAPSKFRTADGRS-UHFFFAOYSA-N acetic acid 4-aminobenzenesulfonamide Chemical compound S(=O)(C1=CC=C(C=C1)N)(=O)N.C(C)(=O)O MDAPSKFRTADGRS-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 208000003796 chancre Diseases 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 229940124567 diuretic antihypertensive agent Drugs 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 230000005560 droplet transmission Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000003736 gastrointestinal content Anatomy 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 210000000777 hematopoietic system Anatomy 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000008991 intestinal motility Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000036445 liquid secretion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000030208 low-grade fever Diseases 0.000 description 1
- -1 lycopodine Chemical class 0.000 description 1
- BCZFSDNVXODRAJ-JTTNIQEDSA-N lycopodine Chemical compound C1CCN2CCC[C@@H]3[C@H]4C[C@@H](C)C[C@]32[C@H]1C(=O)C4 BCZFSDNVXODRAJ-JTTNIQEDSA-N 0.000 description 1
- BCZFSDNVXODRAJ-ZHMBSYLPSA-N lycopodine Natural products C1CCN2CCC[C@@H]3[C@H]4C[C@H](C)C[C@]32[C@H]1C(=O)C4 BCZFSDNVXODRAJ-ZHMBSYLPSA-N 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- NWFYESYCEQICQP-UHFFFAOYSA-N methylmatairesinol Natural products C1=C(OC)C(OC)=CC=C1CC1C(=O)OCC1CC1=CC=C(O)C(OC)=C1 NWFYESYCEQICQP-UHFFFAOYSA-N 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001734 parasympathetic effect Effects 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- FFWOKTFYGVYKIR-UHFFFAOYSA-N physcion Chemical compound C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1O FFWOKTFYGVYKIR-UHFFFAOYSA-N 0.000 description 1
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 1
- OISYIJRGMYJBRH-UHFFFAOYSA-N physcione Natural products COc1cc(O)c2C(=O)c3ccc(O)cc3C(=O)c2c1 OISYIJRGMYJBRH-UHFFFAOYSA-N 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000001533 respiratory mucosa Anatomy 0.000 description 1
- 210000001995 reticulocyte Anatomy 0.000 description 1
- 230000003307 reticuloendothelial effect Effects 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 230000005760 tumorsuppression Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种用治疗急性出疹性传染疾病的中药丸剂及制备方法,属中药领域。本发明药物有效成分的原料组成及重量份数为:山药68~85g、当归65~82g、枸杞子63~78g、熟地60~74g、黄芪57~70g、芸薹55~67g、毛冬青53~65g、夜交藤50~62g、莎草46~58g、大枣43~54g、柳枝39~50g、巴戟天36~47g、党参33~45g、陈皮30~42g、寻骨风28~38g、芥穗25~35g、黑头草23~32g、香艾20~28g、松针18~25g、紫靛15~22g、牛蒡子12~18g、灵香草9~16g、甘草6~12g、白鲜皮4~9g、蝉蜕2~6g。本发明选用药材药性相适相辅,针对病因对症下药,有清热解毒、祛风止痒、补血活血、理气固表之功效,吸收效果好,疗效显著,无毒副作用及临床不良反应,经临床验证对风疹治愈率较高。
Description
所属技术领域
本发明涉及中药领域,尤其涉及一种用治疗急性出疹性传染疾病的中药丸剂及制备方法。
背景技术
风疹是由风疹病毒(RV)引起的急性出疹性传染疾病,临床上以前驱期短、低热、皮疹和耳后、枕部淋巴结肿大为特征。一般病情较轻,病程短,预后良好。但孕妇感染风疹,将会导致胎儿严重损害。引起先天性风疹综合征(FRS)。
现代医学认为本病由风疹病毒(RNA病毒)通过空气飞沫传播侵入人体,在呼吸道粘膜增殖后进入血液循环引起原发性病毒血症,可通过白细胞到网状内皮系统,受染的网状内皮细胞坏死,病毒释放再次入血,引起继发性病毒血症,出现发热,呼吸道症状及淋巴结肿大。西医主要是支持疗法,对症治疗。可酌情给予退热剂,止咳剂及镇痛剂。喉痛用复方硼砂液漱口,皮肤瘙痒可用炉甘石洗剂或生油涂拭,结膜炎用o.25%氧霉素滴眼液或10%醋酸磺胺液滴眼数日。但这些治疗方法并非针对风疹的特效药物,疗效并不理想,且具有一定的副作用。
中医学认为本病是由于外感风热时邪,由口鼻而人,郁于肺卫,蕴于肌腠,与气直相搏,发于皮肤所致。本发明所述药丸是经长期临床验证总结配置而成,针对病因对症下药,具有清热解毒、祛风止痒、补血活血、理气固表之功效,吸收效果好,疗效显著,无毒副作用及临床不良反应,经临床验证对风疹治愈率较高。
发明内容
本发明提供了一种用治疗急性出疹性传染疾病的中药丸剂及制备方法,具有清热解毒、祛风止痒、补气活血、理气固表之功效,治病求源标本兼治,对风疹具有很好的疗效。
为实现上述目的,本发明的技术方案实施如下:
一种用治疗急性出疹性传染疾病的中药丸剂,制成所述药物有效成分的原料组成及重量份数为:
山药68~85g 当归65~82g 枸杞子63~78g 熟地60~74g 黄芪57~70g
芸薹55~67g 毛冬青53~65g 夜交藤50~62g 莎草46~58g 大枣43~54g
柳枝39~50g 巴戟天36~47g 党参33~45g 陈皮30~42g 寻骨风28~38g
芥穗25~35g 黑头草23~32g 香艾20~28g 松针18~25g 紫靛15~22g
牛蒡子12~18g 灵香草9~16g 甘草6~12g 白鲜皮4~9g 蝉蜕2~6g
制成所述药物有效成分的原料组成及重量份数为:
山药72~82g 当归68~78g 枸杞子66~75g 熟地63~71g 黄芪60~67g
芸薹58~64g 毛冬青56~62g 夜交藤53~59g 莎草50~55g 大枣46~52g
柳枝42~47g 巴戟天39~44g 党参35~42g 陈皮33~39g 寻骨风31~35g
芥穗28~32g 黑头草25~29g 香艾22~25g 松针20~23g 紫靛17~20g
牛蒡子14~16g 灵香草12~14g 甘草8~10g 白鲜皮5~7g 蝉蜕3~5g
制成所述药物有效成分的原料组成及重量份数为:
山药77g 当归74g 枸杞子71g 熟地67g 黄芪64g
芸薹61g 毛冬青59g 夜交藤56g 莎草53g 大枣50g
柳枝45g 巴戟天42g 党参39g 陈皮35g 寻骨风33g
芥穗30g 黑头草27g 香艾24g 松针22g 紫靛18g
牛蒡子15g 灵香草13g 甘草9g 白鲜皮6g 蝉蜕4g
一种用治疗急性出疹性传染疾病的中药丸剂的制备方法,包括以下工艺步骤:
(1)将枸杞子、芸薹、毛冬青、夜交藤、莎草、大枣、柳枝、陈皮、芥穗、黑头草、紫靛、牛蒡子、灵香草、甘草、白鲜皮、蝉蜕洗净、晾干后混合均匀,放入容器中,在容器中加入6~8倍量的水,加热煮沸3~4小时,冷却后取浸液;在剩余的药渣中再加入4~6倍量的水,加热煮沸2~3小时,冷却后浸液;合并两次所得浸液,加热,蒸发浓缩为相对密度1.15~1.20的稠膏,备用;
(2)将当归、熟地、巴戟天、党参、寻骨风、香艾、松针洗净放入容器中,加入3~5倍量的绍兴黄酒,煮沸后放凉,继续浸泡3~5小时,取浸液;在剩余的药渣中再加入2~4倍量的绍兴黄酒,煮沸后放晾,继续浸泡2~4小时,取浸液;合并两次所得浸液,加蒸蒸发浓缩为相对密度1.10~1.20的稠膏,备用;
(3)将黄芪放入铁锅中,文火微炒,炒至表皮变黄后,取出放凉,粉碎研末,过120目细筛,得细粉,备用;
(4)先将麸皮均匀撒布于热锅内,俟烟起,加入山药片拌炒至淡黄色为度,取出,筛去麸皮,放凉,晒干,粉碎研末,过120目细筛,得细粉,备用;
(5)将步骤(1)、步骤(2)所得的稠膏,与步骤(3)、步骤(4)中所得的细粉混合,加入炼蜜搅拌均匀后,制备为每粒8g的药丸。
本发明所用中药的药性如下:
山药:味甘;性平。入肺;脾;肾经。补脾;养肺;固肾;益精。主治脾虚泄泻;食少浮肿;肺虚咳喘;消渴;遗精;带下;肾虚尿频;外用治痈肿;瘰疬。《本草正》载:“山药,能健脾补虚,滋精固肾,治诸虚百损,疗五劳七伤。”现代医学研究证实,山药能降低血糖,调节机体对非特异刺激反应性,有效对抗环磷酰胺的抑制免疫作用,刺激小肠运动,促进肠道内容物排空,此外还能助消化、止泻、祛痰。
当归:味甘;辛;性温。归肝、心、脾经。补血活血;调经止痛;润肠通便。主治血虚萎黄;眩晕心悸;虚寒腹痛;风湿痹痛;跌扑损伤;痈疽疮疡。《本草正》载:“其味甘而重,故专能补血,其气轻而辛,故又能行血,能养营养血,补气生精,安五脏,强形体,益神志,凡有形虚损之病,无所不宜。”现代医学研究证实,当归具有抗菌、消炎作用,对慢性风湿关节炎急性发作有明显的抑制作用。
枸杞子:味甘;性平。归肝;肾;肺经。养肝;滋肾;润肺。主治肝肾亏虚;头晕目眩;目视一清;腰膝酸软;阳痿贵精;虚劳咳嗽;消渴引饮。《本草正》载:“明耳目,添精固髓,健骨强筋,善补劳伤,尤止消渴。”现代医学研究证实,枸杞子可调节机体免疫功能、能有效抑制肿瘤生长和细胞突变,具有延缓衰老、抗脂肪肝、调节血脂和血糖、促进造血功能等方面的作用。
熟地:味甘;性温;归肝;肾经。补血滋润;益精填髓。主治血虎萎黄;眩晕心悸;肝肾阴亏;腰膝酸软;肾虚喘促。《本草汇言》载:“久病阴伤,新产血败,在所必需者也。”现代医学研究证实,熟地可增强GSH-Px活性,降低血清中LPO的含量,提高血浆AD浓度,此外与骨髓造血系统亦有密切相关的作用。
黄芪:味甘;性温。入心;肺;脾;肾经。补气固表;利尿;托毒排脓;生肌敛疮。主治气短心悸;倦怠;乏力;自汗;盗汗;久泻;脱肛;体虚浮肿;子宫脱垂;慢性肾炎;痈疽难溃;或溃久不敛。《新华本草纲要》载:“有补气固表、托毒排脓、生肌的功能。”现代医学研究证实,黄芪主要成分为黄芪总黄酮、黄芪总多糖、黄芪总皂苷和氨基酸等,具有利尿降压、消炎镇痛、强心、抗氧自由基生成及提高机体免疫功能等多种药理作用,可从多方面作用于机体,改善心血管、脑血管、糖尿病、肾病等相关血管性病变患者的血流动力学和血管内皮细胞等功能。
芸薹:味辛;甘;性平。肺;肝;脾经。凉血散血;解毒消肿。主治血痢;丹毒;热毒疮肿;乳痈;风疹;吐血。《本草纲目》:治瘭疽,豌豆疮,散血消肿。
毛冬青:味苦;涩;性寒。入肺;肝;大肠经。清热解毒;活血通络。主治风湿感冒;肺热咳喘;咽痛;乳蛾;牙龈肿痛;胸痹心痛;中风偏瘫;血栓闭塞性脉管炎;丹毒;烧烫伤;痈疽;中心性视网膜炎。《广西中草药》载:“清热解毒,消肿止痛,利小便,活血通脉,治血栓闭塞性脉管炎,冠心病,脑血管意外所致的偏瘫。”现代医学研究证实,毛冬青有显著的扩张血管作用,抗菌消炎,促进愈合,有效溶解瘀块和血栓,修复瓣膜使表皮坏死细胞再生,激活血管神经,对多种细胞有抑制或杀灭作用。
夜交藤:味甘;微苦;性平。入心;肝经。养心安神;祛风;通络。主治失眠;多梦;血虚身痛;肌肤麻木;风湿痹痛;风疹瘙痒。《饮片新参》载:“养肝肾,止虚汗,安神催眠,补中气,行经络,通血脉,治劳伤。”现代医学研究证实,夜交藤含有大黄素、大黄素甲醚,与戊巴比妥钠呈协同作用,有显著的镇静、催眠作用,尤其是延长慢波睡眠时相。
莎草:味苦;辛;性凉。归肝;肺经。行气开郁;祛风止痒;宽胞利痰。主治胸闷不舒;风疹瘙痒;痈伴随肿毒。《履巉岩本草》:治皮肤瘙痒,遍体生风。
大枣:味甘;温。归脾;胃经。补脾胃;益气血;安心神;调营卫;和药性。主治脾胃虚弱;气血不足;食少便溏;倦怠乏力;心悸失眠;妇人脏躁;营卫不和。《本草汇言》:沈氏曰,此药甘润膏凝,善补阴阳、气血、津液、脉络、筋俞、骨髓,一切虚损,无不宜之。如龙谭方治惊悸怔忡,健忘恍惚,志意昏迷,精神不守,或中气不和,饮食无味,百体懒重,肌肉瘦,此属心、脾二藏元神亏损之证,必用大枣治之。佐用陈皮,调畅中脘虚滞之痰。
柳枝:味苦;性寒。归胃;肝经。祛风利湿;解毒消肿。主治风湿痹痛;小便淋浊;黄疸;风疹瘙痒;疔疮;丹毒,龋齿;龈肿。《得配本草》:去风热,除湿痹。
巴戟天:味苦;辛;性温。入肝经。祛风除湿;通经活络;消肿止痛。主治风湿腰腿痛;关节疼痛;跌打损伤;刀伤;烫火伤。《湖南药物志》载:“舒筋活血,补气通络。治腰痛,关节痛,闭经。”现代医学研究表明,伸筋草含有石松碱、棒石松宁碱等生物碱,以及萜类化合物、甾醇和酸类,有降温、降血压作用,能增强心脏收缩力度,兴奋平滑肌,此外还有抑菌作用。
党参:味甘;性平。归脾;肺经。健脾补肺;益气生津。主治脾胃虚弱;食少便溏;四肢乏力;肺虚喘咳;气短自汗;气血两亏诸证。《德配本草》载:“清肺金,补元气,开声音,助筋力。”现代医学研究证实,党参能调节胃肠运动、抗溃疡、增强免疫功能,对兴奋和抑制两种神经过程都有影响,能升高红细胞、血红蛋白、网织红细胞,还有延缓衰老和抗氧化、抗辐射、降压的作用。
陈皮:味辛;甘;性寒。入脾;胃经。下气;调中;化痰;醒酒。主治饮食失调;上气烦满;伤酒口渴。《日华子本草》载:“皮炙作汤,可解酒毒及酒渴,伤寒饮食劳复者,浓煎汁服。”医学临床研究表明,陈皮所含的橙皮苷可抑制胃溃疡,降低毛细血管通透性,具有调整肠胃功能以及抗炎作用,其挥发油具有祛痰、平喘、促进消化液分泌和排除肠内积气等作用,此外还有扩张冠状动脉、降低血压和利胆等作用。
寻骨风:味苦;性平;归肝经。祛风除湿,活血通络;止痛。主治风湿痹痛,肢体麻木,筋骨拘挛,跌打损伤疼痛;外伤出血;乳痈及多种化脓性感染。《饮片新参》载:“散风痹,通络,治骨节痛。”现代医学研究证实,寻骨风所含的生物碱对蛋清性关节炎有明显的预防作用,经乙醇提取得所的制剂对蛋清性及甲醛性关节炎均有效果。
芥穗:味辛;微苦;性微温。入肺;肝经。祛风;解表;透疹;止血。主治感冒发热;头痛;目痒;咳嗽;咽喉肿痛;麻疹;痈肿;疮疥;衄血;吐血;便血;崩漏;产后血晕。《滇南本草》载:“治跌打损伤,并敷毒疮。治吐血。荆芥穗,上清头目诸风,止头痛,明目,解肺、肝、咽喉热痛,消肿,除诸毒,发散疮痈。治便血,止女子暴崩,消风热,通肺气鼻窍塞闭。”现代医学研究证明,芥穗有显著的解热镇痛功效,对金黄色葡萄球菌和白喉杆菌有较强的抗菌作用,对炭疽杆菌、乙型链球菌、伤寒杆菌、痢疾杆菌、绿脓杆菌、人型结核杆菌等均表现一定的抑制作用,炒炭后有止血作用,此外还有一定的抑制癌细胞的作用。
黑头草:味苦;辛;性凉。清热解毒;祛风止痒。主治口疮;丹毒;风疹;湿疹;脚气。
香艾:味辛;微苦;性温。祛风;除湿;止痒;止血。主治风寒湿痹;关节疼痛;风疹;湿疹;皮肤瘙痒;外伤出血。
松针:味苦;性温。归心;脾经。祛风燥湿;杀虫止痒;活血安神。主治风湿痿痹;脚气;湿疮;癣;风疹瘙痒;跌打损伤;神经衰弱;慢性肾炎;高血压病。预防乙脑、流感。《生草药性备要》:杀兹,干水,止痒,埋口(合疮口),洗疳疮,治兹疥。
紫靛:味辛;苦;性凉。清肺化痰;祛风利湿;解毒消肿。主治肺热咳嗽;百日咳;风湿疼痛;风疹身痒;黄水疮;小便淋痛;跌打瘀肿;痈肿疮疖。
牛蒡子:味辛;苦;性寒。归肺;胃经。疏散风热;宣肺透疹;利咽散结;解毒消肿。主治风热咳嗽;咽喉肿痛;斑疹不透;风疹瘙痒;疮疡肿毒。《药品化义》载:“能升能降,力解热毒,苦能清火,辛能疏风,主上部风痰,面目浮肿,咽喉不利,诸毒热壅。”现代医学研究表明,牛蒡子可抑制尿蛋白排泄,改善血清生化指标,对金黄色葡萄球菌、星形奴兴氏菌、腹股沟表皮癣菌均有抑制作用,能显著而持久地降低血糖,对子宫及肠管有抑制作用,所含的牛蒡甙元有抗癌活性。
灵香草:味辛;性凉。清热解毒;散风止痒。主治头痛;头晕;口舌生疮;咽喉红肿;水火烫伤;风疹;疥癣。
甘草:味甘;性平。归心;肺;脾;胃经。补脾益气;清热解毒;祛痰止咳;缓急止痛;调和诸药。主治脾胃虚弱;倦怠乏力;心悸气短;咳嗽痰多;脘腹四脚挛急疼痛;痈肿疮毒;缓解药物毒性。《本草纲目》载:“诸药中甘草为君。治七十二种乳石毒,解一千二百般草本毒,调和从药有功。”现代医学研究证实,甘草有较强的解毒作用,还有抗溃疡、抗炎症、镇痉镇咳、降血压、降血脂、抗癌作用,广泛用于治疗咽喉炎、喉炎、气管炎、支气管炎、哮喘、咳嗽、咳血等疾病,此外还具有抗胃溃疡、抗胃炎作用。
白鲜皮:味苦;咸;寒。归脾;肺;小肠;胃;膀胱经。清热燥湿;祛风止痒;解毒。主治风热湿毒所致的风疹;湿疹;疥癣;黄疸;湿热痹痛。《本草原始》:白鲜皮,入肺经,故能去风,入小肠经,故能去湿,夫风湿既除,则血气自活而热亦去。治一切疥癞、恶风、疥癣、杨梅、诸疮热毒。
蝉蜕:味甘;咸;性凉。入肺;肝经。宣散风热;透疹利咽;退翳明目;祛风止痉。主治风热感冒;咽喉肿痛;咳嗽音哑;顽疹不透;风疹瘙痒;目赤翳障;惊痫抽搐;破伤风。《纲目》载:“治头风眩运,皮肤风热,痘疹作痒,破伤风及疗肿毒瘤,大人失音,小儿噤风天吊,惊哭夜啼,阴肿。”现代医学研究证实,蝉蜕具有明显的抗惊厥、镇静作用,能阻断颈上副交感神经的传导,广泛应用于治疗破伤风、慢性荨麻诊、化脓性中耳炎、血管神经性水肿,此外还有止咳嗽,特别是喉痒之咳的作用。
本发明与现有技术相比,具有以下有益效果:
本发明选用药材的药性相适相辅,针对病因对症下药,有清热解毒、祛风止痒、补血活血、理气固表之功效,吸收效果好,疗效显著,无毒副作用及临床不良反应,经临床验证对风疹治愈率较高。
具体实施方式
下面结合具体实施例对本发明做进一步阐述。
实施例1
本发明药物有效成分的原料组成及重量为:
山药68~85g 当归65~82g 枸杞子63~78g 熟地60~74g 黄芪57~70g
芸薹55~67g 毛冬青53~65g 夜交藤50~62g 莎草46~58g 大枣43~54g
柳枝39~50g 巴戟天36~47g 党参33~45g 陈皮30~42g 寻骨风28~38g
芥穗25~35g 黑头草23~32g 香艾20~28g 松针18~25g 紫靛15~22g
牛蒡子12~18g 灵香草9~16g 甘草6~12g 白鲜皮4~9g 蝉蜕2~6g
本发明药物制备方法的工艺步骤为:
(1)将枸杞子、芸薹、毛冬青、夜交藤、莎草、大枣、柳枝、陈皮、芥穗、黑头草、紫靛、牛蒡子、灵香草、甘草、白鲜皮、蝉蜕洗净、晾干后混合均匀,放入容器中,在容器中加入6~8倍量的水,加热煮沸3~4小时,冷却后取浸液;在剩余的药渣中再加入4~6倍量的水,加热煮沸2~3小时,冷却后浸液;合并两次所得浸液,加热,蒸发浓缩为相对密度1.15~1.20的稠膏,备用;
(2)将当归、熟地、巴戟天、党参、寻骨风、香艾、松针洗净放入容器中,加入3~5倍量的绍兴黄酒,煮沸后放凉,继续浸泡3~5小时,取浸液;在剩余的药渣中再加入2~4倍量的绍兴黄酒,煮沸后放晾,继续浸泡2~4小时,取浸液;合并两次所得浸液,加蒸蒸发浓缩为相对密度1.10~1.20的稠膏,备用;
(3)将黄芪放入铁锅中,文火微炒,炒至表皮变黄后,取出放凉,粉碎研末,过120目细筛,得细粉,备用;
(4)先将麸皮均匀撒布于热锅内,俟烟起,加入山药片拌炒至淡黄色为度,取出,筛去麸皮,放凉,晒干,粉碎研末,过120目细筛,得细粉,备用;
(5)将步骤(1)、步骤(2)所得的稠膏,与步骤(3)、步骤(4)中所得的细粉混合,加入炼蜜搅拌均匀后,制备为每粒8g的药丸。
用法用量:口服,每日3次,每次2丸,饭前一小时以温开水或温黄酒送服,7天为一个疗程。
实施例2
本发明药物有效成分的原料组成及重量为:
山药72~82g 当归68~78g 枸杞子66~75g 熟地63~71g 黄芪60~67g
芸薹58~64g 毛冬青56~62g 夜交藤53~59g 莎草50~55g 大枣46~52g
柳枝42~47g 巴戟天39~44g 党参35~42g 陈皮33~39g 寻骨风31~35g
芥穗28~32g 黑头草25~29g 香艾22~25g 松针20~23g 紫靛17~20g
牛蒡子14~16g 灵香草12~14g 甘草8~10g 白鲜皮5~7g 蝉蜕3~5g
本实施例的药物制备方法工艺步骤及用法用量与实施例1相同。
实施例3
本发明药物有效成分的原料组成及重量为:
山药77g 当归74g 枸杞子71g 熟地67g 黄芪64g
芸薹61g 毛冬青59g 夜交藤56g 莎草53g 大枣50g
柳枝45g 巴戟天42g 党参39g 陈皮35g 寻骨风33g
芥穗30g 黑头草27g 香艾24g 松针22g 紫靛18g
牛蒡子15g 灵香草13g 甘草9g 白鲜皮6g 蝉蜕4g
本实施例的药物制备方法工艺步骤及用法用量与实施例1相同。
临床资料:
1、病例选择
选择我院确诊的风疹患者80例临床观察,病人随机分成两组。治疗组40例,其中男性21例,女性19例,年龄5~32岁,平均年龄14.6岁。对照组40例,其中男性23例,女性17例,年龄5~30岁,平均年龄12.3岁。两组资历基本一致,无显著差异,具有可比性。
2、治疗组患者服用本发明药物,口服,每日3次,每次2丸,饭前一小时以温开水或温黄酒送服,7天为一个疗程,服用2个疗程。对照组根据诊断出的风疹的病情,分别予以对症的退热剂、止咳剂、镇痛剂、复方硼砂液、炉甘石洗剂或生油等传统西医治疗手段。
3、疗效判定:
(1)痊愈:临床症状消失,身体状况恢复正常。
(2)好转:临床症状明显减轻,身体状况明显好转。
(3)无效:症状同施治前无明显差异。
4、结果
治疗组中治愈31例,好转7例,无效2例,治愈率77.5%,总有效率95%。
对照组中治愈24例,好转11例,无效5例,治愈率60%,总有效率87.5%。
以上结果显示,治疗组的治愈率和总有效率明显高于对照组。
典型病例举例:
1、孙××,男,6岁。该患者先是颈部长了一些红色斑疹,后蔓延到脸部及背部,非常骚痒,且伴有发烧、咳嗽等症状。后来来院问诊,诊断为风疹,服用本发明药物,口服,每日3次,每次2丸,饭前一小时以温开水送服,7天为一个疗程,服用1个疗程后,上述症状基本消失,只有少量红色斑疹存在,继续服用1个疗程后,身体状况完全恢复正常,已痊愈。
2、何××,女,31岁,工人。该患者脸部、背部和手臂上有很多红色斑疹,瘙痒难耐,且伴有头痛、没食欲、乏力及喷嚏等症状,后来来院问诊,诊断为风疹,服用本发明药物,口服,每日3次,每次2丸,饭前一小时以温开水或温黄酒送服,7天为一个疗程,服用2个疗程后,上述症状完全消失,身体状况完全恢复正常,已痊愈。
本发明所述的药丸所选的药材药性相适相辅,针对病因对症下药,方中党参、山药、枸杞子、黄芪、陈皮、大枣等中药可健脾益气、补气固表;方中当归、熟地等中药可补养营血、活血调经;方中毛冬青、巴戟天、寻骨风等中药可祛风除湿、活血通络;方中柳枝、芥穗、香艾、黑头草、紫靛、牛蒡子、灵香草、白鲜皮、蝉蜕等中药可祛风利湿、解毒消肿、透疹止痒;方中甘草可清热解毒、调和诸药。方中诸药合用,有清热解毒、祛风止痒、补血活血、理气固表之功效,吸收效果好,疗效显著,无毒副作用及临床不良反应,经临床验证对风疹治愈率较高。
Claims (4)
1.一种用治疗急性出疹性传染疾病的中药丸剂,其特征在于:制成所述药物有效成分的原料组成及重量份数为:
。
2.根据权利要求1所述的一种用治疗急性出疹性传染疾病的中药丸剂,其特征在于:制成所述药物有效成分的原料组成及重量份数为:
。
3.根据权利要求1所述的一种用治疗急性出疹性传染疾病的中药丸剂,其特征在于:制成所述药物有效成分的原料组成及重量份数为:
。
4.一种用治疗急性出疹性传染疾病的中药丸剂的制备方法,其特征在于:包括以下工艺步骤:
(1)将枸杞子、芸薹、毛冬青、夜交藤、莎草、大枣、柳枝、陈皮、芥穗、黑头草、紫靛、牛蒡子、灵香草、甘草、白鲜皮、蝉蜕洗净、晾干后混合均匀,放入容器中,在容器中加入6~8倍量的水,加热煮沸3~4小时,冷却后取浸液; 在剩余的药渣中再加入4~6倍量的水,加热煮沸2~3小时,冷却后浸液;合并两次所得浸液,加热,蒸发浓缩为相对密度1.15~1.20的稠膏,备用;
(2)将当归、熟地、巴戟天、党参、寻骨风、香艾、松针洗净放入容器中,加入3~5倍量的绍兴黄酒,煮沸后放凉,继续浸泡3~5小时,取浸液;在剩余的药渣中再加入2~4倍量的绍兴黄酒,煮沸后放晾,继续浸泡2~4小时,取浸液;合并两次所得浸液,加蒸蒸发浓缩为相对密度1.10~1.20的稠膏,备用;
(3)将黄芪放入铁锅中,文火微炒,炒至表皮变黄后,取出放凉,粉碎研末,过120目细筛,得细粉,备用;
(4)先将麸皮均匀撒布于热锅内,俟烟起,加入山药片拌炒至淡黄色为度,取出,筛去麸皮,放凉,晒干,粉碎研末,过120目细筛,得细粉,备用;
(5)将步骤(1)、步骤(2)所得的稠膏,与步骤(3)、步骤(4)中所得的细粉混合,加入炼蜜搅拌均匀后,制备为每粒8g的药丸。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510133996.8A CN104784415A (zh) | 2015-03-26 | 2015-03-26 | 一种用治疗急性出疹性传染疾病的中药丸剂及制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510133996.8A CN104784415A (zh) | 2015-03-26 | 2015-03-26 | 一种用治疗急性出疹性传染疾病的中药丸剂及制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104784415A true CN104784415A (zh) | 2015-07-22 |
Family
ID=53549909
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510133996.8A Pending CN104784415A (zh) | 2015-03-26 | 2015-03-26 | 一种用治疗急性出疹性传染疾病的中药丸剂及制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104784415A (zh) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105169289A (zh) * | 2015-10-28 | 2015-12-23 | 刘红霞 | 一种用于治疗急性胆管炎的中药丸剂及制备方法 |
| CN105233186A (zh) * | 2015-11-24 | 2016-01-13 | 王文娟 | 一种用于外伤后头痛康复护理的中药丸剂及制备方法 |
| CN105327120A (zh) * | 2015-12-02 | 2016-02-17 | 王雪凤 | 一种用于治疗风湿性多肌痛的中药丸剂及制备方法 |
| CN105343866A (zh) * | 2015-12-18 | 2016-02-24 | 夏修菲 | 一种用于治疗寒饮咳嗽的中药片剂及制备方法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1907378A (zh) * | 2006-08-04 | 2007-02-07 | 胡彩芳 | 一种治疗气血两虚型慢性荨麻疹的汤剂药物及制备方法 |
-
2015
- 2015-03-26 CN CN201510133996.8A patent/CN104784415A/zh active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1907378A (zh) * | 2006-08-04 | 2007-02-07 | 胡彩芳 | 一种治疗气血两虚型慢性荨麻疹的汤剂药物及制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| 刘访文等: "《慢性荨麻疹中医治验》", 《皮肤病与性病》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105169289A (zh) * | 2015-10-28 | 2015-12-23 | 刘红霞 | 一种用于治疗急性胆管炎的中药丸剂及制备方法 |
| CN105233186A (zh) * | 2015-11-24 | 2016-01-13 | 王文娟 | 一种用于外伤后头痛康复护理的中药丸剂及制备方法 |
| CN105327120A (zh) * | 2015-12-02 | 2016-02-17 | 王雪凤 | 一种用于治疗风湿性多肌痛的中药丸剂及制备方法 |
| CN105343866A (zh) * | 2015-12-18 | 2016-02-24 | 夏修菲 | 一种用于治疗寒饮咳嗽的中药片剂及制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104189789A (zh) | 一种治疗急性传染性黄疸型肝炎的中药组合物 | |
| CN103536778B (zh) | 一种治疗偏头痛的中药制剂 | |
| CN105311581A (zh) | 一种预防和治疗乳腺增生的中药组合物及其制备方法 | |
| CN104784415A (zh) | 一种用治疗急性出疹性传染疾病的中药丸剂及制备方法 | |
| CN103908511B (zh) | 一种治疗软骨瘤的中药药丸及制备方法 | |
| CN102940745B (zh) | 一种用于治疗眼睑痉挛的丸剂 | |
| CN105497784A (zh) | 一种用于治疗血栓性浅静脉炎的中药丸剂及制备方法 | |
| CN104353051A (zh) | 一种治疗胃痛的中药制剂及其制备方法 | |
| CN103356870B (zh) | 一种治疗产后缺乳的中药制剂及制备方法 | |
| CN103285294B (zh) | 一种用于预防与治疗先兆流产的中药及其制备方法 | |
| CN105999110A (zh) | 一种用于治疗女性慢性盆腔疼痛的中药冲剂及制备方法 | |
| CN105435131A (zh) | 一种治疗慢性心衰的中药组合物及其制备方法 | |
| CN105381127A (zh) | 一种辅助针灸治疗周围性面瘫的中药冲剂及制备方法 | |
| CN105381128A (zh) | 一种辅助针灸治疗外周神经麻痹的中药冲剂及制备方法 | |
| CN104740481A (zh) | 一种治疗功能性子宫出血的中药 | |
| CN104274809A (zh) | 一种治疗经期头痛的中药组合物及其制备方法 | |
| CN105434934A (zh) | 一种用于治疗妇科更年期综合症的中药丸剂及制备方法 | |
| CN105535461A (zh) | 一种用于防治小儿风热型感冒的中药片剂及制备方法 | |
| CN105497782A (zh) | 一种用于治疗肾石症的中药丸剂及制备方法 | |
| CN105169295A (zh) | 一种用于治疗产后子宫复旧不全的中药丸剂及制备方法 | |
| CN105663365A (zh) | 一种用于麻醉术后瘙痒疼痛缓解的中药冲剂及制备方法 | |
| CN105311527A (zh) | 一种用于治疗子宫内膜移位症的中药制剂及其制备方法 | |
| CN105456933A (zh) | 一种活血化瘀、通经活络的中药及其制备方法 | |
| CN105687897A (zh) | 一种治疗糖尿病的纯中药制剂及其制备方法 | |
| CN103656343B (zh) | 一种治疗胃溃疡的药物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150722 |